Condition 1: Generalized anxiety disorder. Condition 2: Persistent depressive disorder. Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is "free-floating"). The dominant symptoms are variable but include complaints of persistent nervousne A chronic depression of mood, lasting at least several years, which is not sufficiently severe, or in which individual episodes are not sufficiently prolo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All people with co-morbid generalized anxiety disorder and persistent depressive disorder Age between 18 to 55 years old Ability to read and write in Farsi language
Exclusion criteria
Exclusion criteria: Con-current participation in a psychological treatment program for anxiety and/or depression Receiving a diagnosis of psychotic disorder, substance use disorder, severe personality disorder (such as borderline personality disorder), and/or the bipolar disorder spectrum or having had any of these conditions in the past Having received any form of psychological treatment during the last three months Concurrent participation in a pharmacological treatment program for anxiety and/or depression with variable medication dosage Having any medical condition that affects anxiety and depression (including cancer, chronic pain, thyroid problems, lupus, diabetes, HIV, multiple sclerosis, heart problems, and asthma)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of individuals scoring below 10 on the seven-item Generalized Anxiety Disorder questionnaire (GAD-7). Timepoint: Pre-intervention - Post-intervention - 2-month follow-up. Method of measurement: The seven-item Generalized Anxiety Disorder questionnaire (GAD-7).;The percentage of individuals scoring below 10 on the nine-item Patient Health Questionnaire (PHQ-9). Timepoint: Pre-intervention - Post-intervention - 2-month follow-up. Method of measurement: The nine-item Patient Health Questionnaire (PHQ-9). | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of individuals scoring below 50 on the Emotion Contrast Avoidance Questionnaire. Timepoint: Pre-intervention - sessions 2-4 - Post-intervention - 2-month follow-up. Method of measurement: Emotion Contrast Avoidance Questionnaire.;Percentage of individuals scoring above 10 on the episodic future thinking test. Timepoint: Pre-intervention - sessions 2-4 - Post-intervention - 2-month follow-up. Method of measurement: Episodic future thinking test.;Percentage of individuals scoring below 20 on the work and social adjustment scale. Timepoint: Pre-intervention - Post-intervention - 2-month follow-up. Method of measurement: The work and social adjustment scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kharazmi Univeristy